Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly’s weight-loss drug Zepbound and its diabetes drug Mounjaro.

The group – representing franchised dealers, suppliers and nearly all major automakers – say the upcoming levies could jeopardize U.S. automotive production.

Priced at $7.99 a month, the friend or family member of the primary account owner gets their own standalone account under the same subscription.

The FDA is phasing out the use of petroleum-based synthetic dyes in food and drinks.

The four-floor listing at 111 West 57th St. spans 11,480 square feet and is being pitched as a rare collector’s item for global elites.

Tennis great Andre Agassi will make his professional debut with top player Anna Leigh Waters.

Aerospace suppliers are grappling with higher prices for parts from President Donald Trump’s tariffs.

Fruitist, known for its jumbo blueberries, has surpassed $400 million in annual sales and received backing from Ray Dalio’s family office.

Chipotle is betting that Mexico’s familiarity with its ingredients and appreciation for fresh food will win over consumers.

The results bring Eli Lilly’s pill orforglipron one step closer to becoming a new, needle-free alternative in the booming weight loss and diabetes market.